Roche becomes a common factor in Cytyc and TriPath
This article was originally published in Clinica
Roche Diagnostics has reached a deal with Cytyc to co-market certain of Roche's PCR based tests. The women's health screening and diagnostic tests will be conducted on Roche's Cobas Amplicor automated platform, using samples collected in Cytyc's ThinPrep Pap test collection vials. Initially, the companies will attempt to get US FDA clearance for Chlamydia trachomatis and Neisseria gonorrhea tests.